-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
OrganiGram Holdings Inc. Forecasted to Post Q4 2023 Earnings of ($0.01) Per Share (TSE:OGI)
OrganiGram Holdings Inc. Forecasted to Post Q4 2023 Earnings of ($0.01) Per Share (TSE:OGI)
OrganiGram Holdings Inc. (TSE:OGI – Get Rating) – Atb Cap Markets issued their Q4 2023 earnings per share (EPS) estimates for OrganiGram in a research report issued to clients and investors on Tuesday, November 29th. Atb Cap Markets analyst F. Gomes expects that the company will earn ($0.01) per share for the quarter. The consensus estimate for OrganiGram's current full-year earnings is ($0.07) per share. Atb Cap Markets also issued estimates for OrganiGram's FY2024 earnings at $0.03 EPS.
Get OrganiGram alerts:Separately, Eight Capital dropped their price objective on OrganiGram from C$2.60 to C$1.70 in a research report on Wednesday, August 31st. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of C$2.40.
OrganiGram Trading Up 5.0 %
OrganiGram stock opened at C$1.46 on Thursday. The company has a market capitalization of C$458.01 million and a price-to-earnings ratio of -12.37. The company has a current ratio of 4.17, a quick ratio of 2.96 and a debt-to-equity ratio of 1.48. OrganiGram has a 12 month low of C$1.17 and a 12 month high of C$2.69. The business's fifty day simple moving average is C$1.29 and its two-hundred day simple moving average is C$1.35.OrganiGram Company Profile
(Get Rating)
Organigram Holdings Inc, through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co, Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates.
Read More
- Ford Revving Up Production Of EV Power Units At U.K. Plant
- Are the Short Sellers Still Right About Mullen Automotive stock?
- La-Z-Boy Reclines To More Comfortable Levels
- Is The Recovery Rally Here For SoFi?
- Is Apple Going To Rally Into Year End?
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.
OrganiGram Holdings Inc. (TSE:OGI – Get Rating) – Atb Cap Markets issued their Q4 2023 earnings per share (EPS) estimates for OrganiGram in a research report issued to clients and investors on Tuesday, November 29th. Atb Cap Markets analyst F. Gomes expects that the company will earn ($0.01) per share for the quarter. The consensus estimate for OrganiGram's current full-year earnings is ($0.07) per share. Atb Cap Markets also issued estimates for OrganiGram's FY2024 earnings at $0.03 EPS.
OrganiGram Holdings Inc.(多伦多证券交易所股票代码：OGI-GET Rating)-ATB Cap Markets在11月29日星期二发布给客户和投资者的一份研究报告中，发布了他们对OrganiGram 2023年第四季度每股收益(EPS)的估计。ATB Cap Markets分析师F·戈麦斯预计，该公司本季度每股收益将达到0.01美元。对OrganiGram目前全年收益的普遍估计是每股0.07美元。ATB Cap Markets还发布了OrganiGram 2024财年每股收益预期为0.03美元。
Separately, Eight Capital dropped their price objective on OrganiGram from C$2.60 to C$1.70 in a research report on Wednesday, August 31st. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of C$2.40.
另外，在8月31日星期三的一份研究报告中，Eight Capital将OrganiGram的目标价从2.60加元下调至1.70加元。一名分析师对该股的评级为卖出，两名分析师给出了持有评级，四名分析师给出了该公司股票的买入评级。根据MarketBeat的数据，该股的共识评级为持有，平均目标价为2.40加元。
OrganiGram Trading Up 5.0 %
OrganiGram交易上涨5.0%
OrganiGram Company Profile
OrganiGram公司简介
(Get Rating)
(获取评级)
Organigram Holdings Inc, through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co, Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates.
OrganiGram Holdings Inc.通过其子公司在加拿大生产和销售大麻和大麻衍生产品。它提供医用大麻产品，包括用于平民患者和退伍军人的大麻花、大麻油和雾化器；成人使用的爱迪生大麻公司、Trail Blazer、Shred、Shred‘Ems、Big Bag O’Buds和Monjour品牌的娱乐用大麻；以及大麻食用产品和浓缩物。
Read More
阅读更多内容
- Ford Revving Up Production Of EV Power Units At U.K. Plant
- Are the Short Sellers Still Right About Mullen Automotive stock?
- La-Z-Boy Reclines To More Comfortable Levels
- Is The Recovery Rally Here For SoFi?
- Is Apple Going To Rally Into Year End?
- 福特在英国工厂加速生产电动汽车动力装置
- 卖空者对马伦汽车股票的看法仍然正确吗？
- La-Z-Boy倾斜到更舒适的水平
- 复苏集会是为SoFi而来的吗？
- 苹果会在年底前大涨吗？
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.
接受OrganiGram Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对OrganiGram和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧